Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR-ICR / Cancer Research Society Partnership - Res. Gr. Cancer Prev.

Université de Montréal

$67,500.00

When sweet is too sweet: The impact of artificial sweeteners on postpartum breast cancer

FY 2024-25

Summary
Background & Rationale: Early-onset breast cancer is rising on a global scale, with concerning increases in developing countries independent of race and ethnicity. Dishearteningly, breast cancer in young women has a poor prognosis. Postpartum breast cancer (PPBC)—a subtype of early-onset breast cancer that occurs within 10 years of parturition—carries an elevated risk of death. Known risk factors include age, parity status and breastfeeding history; however, the current increase in early-onset BC may indicate a role for environmental drivers (i.e. exposomes). The impact of exposomes, such as diet, on PPBC remains unknown. One prevalent exposome in the developing world is artificial sweeteners that enhance palatability and are used in food and pharmaceutical products. The NutriNet Santé cohort studies have revealed that individuals with an elevated intake of artificial sweeteners have a higher risk of cancer development. While artificial sweeteners alone do not directly cause cancer, they may amplify carcinogenic effects when combined with other risk factors. For instance, the artificial sweetener saccharin has been shown to increase the risk of bladder cancer in rats when paired with the carcinogen N-methyl-N-nitrosourea (MNU). Recently, we have demonstrated that the artificial sweetener sucralose negatively regulates cancer-specific T cells. Additionally, our preliminary data on murine models of ovarian, pancreatic, and lymphoma reveal that mice supplemented with human-relevant doses of sucralose have a poorer outcome than controls. Around one in five pregnant women in Canada develop gestational diabetes and consume artificial sweeteners to help maintain their blood glucose levels during pregnancy. While poorly absorbed, it has been noted that sucralose can reach the mM range in breast milk. However, how exposure to artificial sweeteners, such as sucralose, affects PPBC risk and development remains unknown. We hypothesize that environmental exposures to artificial sweeteners increase the risk of developing PPBC. Specific Aims: Non-nutritive artificial sweeteners (NNAS) activate sweet taste without the caloric input. The three most consumed NNAS, non-metabolized and considered safe during pregnancy are saccharin, Acesulfame K (ACK) and sucralose. Therefore, we will test the effect of these NNAS on PPBC in a pre-clinical mouse model. Aim 1: Determine the effects of NNAS supplementation in primary and metastatic PPBC. The mammary gland undergoes intense remodelling during pregnancy and postpartum, creating a tumour-promoting niche. Preliminary findings show that sucralose limits tumour-specific T cells while promoting immunosuppressive populations. Therefore, we will evaluate primary tumour growth and lung metastasis using a model of PPBC: forced weaning of BALB/c dams followed by mammary fat pad injection of 66cl4 breast cancer cells one-day post mammary gland involution. Female mice will be exposed to two doses of saccharine, ACK and sucralose within the acceptable daily intake approved by Health Canada during gestation and throughout the experiment.
Program
CIHR-ICR / Cancer Research Society Partnership - Res. Gr. Cancer Prev.
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
537283
Name
Blagih Julianna
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
When sweet is too sweet: The impact of artificial sweeteners on postpartum breast cancer
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$67,500
Cihrequipment2
$0
Programname2
CIHR-ICR / Cancer Research Society Partnership - Res. Gr. Cancer Prev.
Keyworddelim
Cancer
Abstract
Background & Rationale: Early-onset breast cancer is rising on a global scale, with concerning increases in developing countries independent of race and ethnicity. Dishearteningly, breast cancer in young women has a poor prognosis. Postpartum breast cancer (PPBC)—a subtype of early-onset breast cancer that occurs within 10 years of parturition—carries an elevated risk of death. Known risk factors include age, parity status and breastfeeding history; however, the current increase in early-onset BC may indicate a role for environmental drivers (i.e. exposomes). The impact of exposomes, such as diet, on PPBC remains unknown. One prevalent exposome in the developing world is artificial sweeteners that enhance palatability and are used in food and pharmaceutical products. The NutriNet Santé cohort studies have revealed that individuals with an elevated intake of artificial sweeteners have a higher risk of cancer development. While artificial sweeteners alone do not directly cause cancer, they may amplify carcinogenic effects when combined with other risk factors. For instance, the artificial sweetener saccharin has been shown to increase the risk of bladder cancer in rats when paired with the carcinogen N-methyl-N-nitrosourea (MNU). Recently, we have demonstrated that the artificial sweetener sucralose negatively regulates cancer-specific T cells. Additionally, our preliminary data on murine models of ovarian, pancreatic, and lymphoma reveal that mice supplemented with human-relevant doses of sucralose have a poorer outcome than controls. Around one in five pregnant women in Canada develop gestational diabetes and consume artificial sweeteners to help maintain their blood glucose levels during pregnancy. While poorly absorbed, it has been noted that sucralose can reach the mM range in breast milk. However, how exposure to artificial sweeteners, such as sucralose, affects PPBC risk and development remains unknown. We hypothesize that environmental exposures to artificial sweeteners increase the risk of developing PPBC. Specific Aims: Non-nutritive artificial sweeteners (NNAS) activate sweet taste without the caloric input. The three most consumed NNAS, non-metabolized and considered safe during pregnancy are saccharin, Acesulfame K (ACK) and sucralose. Therefore, we will test the effect of these NNAS on PPBC in a pre-clinical mouse model. Aim 1: Determine the effects of NNAS supplementation in primary and metastatic PPBC. The mammary gland undergoes intense remodelling during pregnancy and postpartum, creating a tumour-promoting niche. Preliminary findings show that sucralose limits tumour-specific T cells while promoting immunosuppressive populations. Therefore, we will evaluate primary tumour growth and lung metastasis using a model of PPBC: forced weaning of BALB/c dams followed by mammary fat pad injection of 66cl4 breast cancer cells one-day post mammary gland involution. Female mice will be exposed to two doses of saccharine, ACK and sucralose within the acceptable daily intake approved by Health Canada during gestation and throughout the experiment.
Competitiondate
202502
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Blagih, Julianna
Approvedterm
2 ans 0 mois
Cihrcontribution2
ICR~ $67,500~ $0~
Université de Montréal - $67,500 Grant (2024-25) | Canada Spends